Category
GLP-1 medications such as Ozempic, Wegovy and Mounjaro have made large weight loss far more common in Australia, and with it the question of what happens to skin afterwards. The articles here look at that question directly: what is actually changing in the face and body, what the published research does and does not establish, and what treatment costs in Australia.
Two things run through all of them. First, most of what is called Ozempic face or Mounjaro skin is the effect of losing a lot of weight, and the research has not settled whether the medicines themselves add anything beyond that. Second, anything about your dose is a decision for the prescriber managing your treatment, not something to change for your skin. None of this is advice about your medication. It is here so the conversation with your doctor starts from better information.
GLP-1 & skin
· 6 min read
Mounjaro can lead to a large amount of weight loss over a year or so, and loose skin is a common question on the way. What the research says about pace, recovery, timing and what helps while you are still losing.
Read the postGLP-1 & skin
· 5 min read
Wegovy can lead to losses of around 15% of body weight, and that is the range where loose skin becomes common. What the numbers say, what they cannot tell you, and what to do about it.
Read the postGLP-1 & skin
· 8 min read
Ozempic face is media shorthand, not a diagnosis. What is really happening after rapid weight loss, why Mounjaro and Wegovy face are the same thing, what treatment costs in Australia, and what Medicare covers.
Read the postGLP-1 & skin
· 6 min read
Fast loss is the reason people are usually given for loose skin. The mechanism is sound, but the evidence is thinner than the confident version suggests. Here is the honest picture.
Read the postGLP-1 & skin
· 2 min read
An honest Australian cost guide for loose-skin treatment after weight loss, from topicals to surgery, plus what Medicare actually covers.
Read the post